May 28, 2017 5:57 AM ET

Life Sciences Tools and Services

Company Overview of Aragen Bioscience, Inc.

Company Overview

Aragen Bioscience, Inc. provides preclinical contract research and development services. The company specializes in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, primary and immortalized cell-based assays, in vivo models of human disease and custom immunological services for the pharmaceutical and biotech industries. Its cell line development services include molecular biology and cell culture, cell line productivity and stability studies, cell culture, and analytical services; molecular biology services comprise isolation of nucleic acids, RT-PCR detection methods and generation of cDNA, primer design, vector const...

380 Woodview Avenue

Morgan Hill, CA 95037

United States

Founded in 2006





Key Executives for Aragen Bioscience, Inc.

Chief Executive Officer
Chief Technology Officer and Vice President
Director of Pre-Clinical Research Services
Director of Cell Biology
Compensation as of Fiscal Year 2016.

Aragen Bioscience, Inc. Key Developments

Kyowa Hakko Kirin, Biowa File Suit Against Aragen Bioscience, Inc. and Transposagen, Inc

Kyowa Hakko Kirin Co. Ltd. and BioWa Inc. announced that they have filed a patent infringement lawsuit against Aragen Bioscience, Inc. and Transposagen, Inc. in the United States District Court for the Northern District of California. In the suit, Kyowa Hakko Kirin and BioWa allege infringement of three patents-U.S. Patent Nos. 6,946,292, 7,425,446, and 8,067,232-related to their award-winning alpha-(1,6)- fucosyl transferase-knockout host cell lines and protein expression. Filed on October 17, 2016 (local time), the suit seeks an injunction, as well as reparation for damages resulting from the infringement.

Aragen Bioscience, Inc. Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016

Aragen Bioscience, Inc. Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016 . Venue: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116, United States.

Aragen Bioscience, Inc. Appoints Oren Beske as President

Aragen Bioscience, Inc. has appointed Oren Beske, Ph.D. as the President of company. Dr. Beske joined company in 2007 as Director, In Vitro Services and has held various leadership positions in the company. Most recently he has served as the Chief Operating Officer and went on to be the Chief Technology and Business Officer.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aragen Bioscience, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at